出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/09/14 01:20:24」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse.
  • Ogden A1, Rida PC1, Knudsen BS2, Kucuk O3, Aneja R4.
  • Cancer letters.Cancer Lett.2015 Oct 28;367(2):89-92. doi: 10.1016/j.canlet.2015.06.025. Epub 2015 Jul 13.
  • Although docetaxel significantly improves survival in a variety of malignancies, its clinical utility is severely restricted by acquired chemoresistance and disease relapse. To uncover the mechanisms underlying these all too common occurrences, an abundance of research has focused on mutations and g
  • PMID 26185000
  • Dose intensity and toxicity associated with Taxotere formulation: a retrospective study in a population of breast cancer patients treated with docetaxel as an adjuvant or neoadjuvant chemotherapy.
  • Chanat C1, Delbaldo C, Denis J, Bocaccio F, Cojean-Zelek I, Le Guyader N.
  • Anti-cancer drugs.Anticancer Drugs.2015 Oct;26(9):984-9. doi: 10.1097/CAD.0000000000000265.
  • Docetaxel is an antineoplastic drug from the taxane family that inhibits tubulin polymerization. Its brand name is Taxotere. In mid-2010, the formulation of Taxotere changed from a two-vial preparation needing a predilution (T2V) to a one-vial ready-to-use preparation (T1V). The aim of this study wa
  • PMID 26237498
  • Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
  • Cho H1, Nishiike S1, Yamamoto Y1, Takenaka Y1, Nakahara S1, Yasui T1, Hanamoto A1, Inohara H2.
  • Auris, nasus, larynx.Auris Nasus Larynx.2015 Oct;42(5):396-400. doi: 10.1016/j.anl.2015.02.009. Epub 2015 Feb 23.
  • OBJECTIVE: The first-line treatment for inoperable recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) has long been the combination of cisplatin and fluorouracil (PF). Recently, cetuximab has been shown to provide an additional survival benefit to PF. It remains unknown whether do
  • PMID 25721854


  • Preoperative chemoradiotherapy with docetaxel, doxifluridine, and low-dose cisplatin for stage Ⅱ/Ⅲ squamous cell carcinoma of the esophagus
  • Yuasa Yasuhiro,Okitsu Hiroshi,Goto Masakazu [他]
  • Esophagus : official journal of the Japan Esophageal Society 12(2), 191-198, 2015-04
  • NAID 40020440638
  • Nintedanib
  • 金田 裕靖,中川 和彦
  • 腫瘍内科 = Clinical oncology 15(2), 204-209, 2015-02
  • NAID 40020372066
  • 術前にDCS療法を行い組織学的CRが得られた4型進行胃癌の1切除例
  • 高屋 誠吾,Kader Abdul A.T.M,宮谷 幸造,黒田 博彦,松永 知之,福本 陽二,尾崎 知博,齊藤 博昭,若月 俊郎,池口 正英
  • 米子医学雑誌 66(1), 7-11, 2015-01-31
  • NAID 120005538082


(doe-se-TAKS-sel) Trade name: Taxotere ® uses generic drug names in all descriptions of drugs. Taxotere is the trade name for docetaxel. In some cases, health care professionals may use the trade name ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. TAXOTERE ® (docetaxel) Injection ...



拡張検索docetaxel hydrate



docetaxel DTX
ドセタキセル水和物 docetaxel hydrate
Taxotere タキソテール TXT?


  • ドセタキセルはチューブリンの重合を促進し、安定な微小管を形成するとともに、その脱重合を抑制する。また、細胞内においては形態的に異常な微小管束を形成する。以上の作用により細胞の有糸分裂を停止させる。


  • タキソテール点滴静注用80mg/タキソテール点滴静注用20mg


  [★] ドセタキセル docetaxel

docetaxel hydrate」

  [★] ドセタキセルドセタキセル水和物